Clinical Trial 50341

Marlton, NJ 08053


Summary:

A Phase 1, Open-label, Multicohort Study to Evaluate the Impact of Inhibitors and Inducers of Cytochrome P450 Enzyme (CYP)3A and/or P-glycoprotein (P-gp) on the Pharmacokinetics (PK) of Vesatolimod (VES) in Virologically Suppressed Adults With HIV-1 on Antiretroviral Therapy (ART).


Qualified Participants Must:

• Be atleast 18 years old
• Be diagnosed with HIV-1
• Be currently on an ART regimen for at least 6 consecutive months, with no change in the ART regimen within 2 months prior to screening
• Refrain from the use of nicotine or nicotine-containing products 90 days prior to first dose of study drug and during the course of the study through the follow-up visit


Qualified Participants May Receive:

  • Up to $4,000
  • Tranportation available and no insurance needed


Available At:

CenExel HRI
30 Lake Center Dr.
Marlton, NJ 08053
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.